Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Neutrophil gelatinase-associated lipocalin (NGAL) is a wellknown biomarker of acute kidney injury. We evaluated the value of plasma NGAL (pNGAL) as an independent predictor of prognosis in immunoglobulin A nephropathy (IgAN). Methods: In total, 91 patients with biopsy-proven IgAN at a single center were evaluated. pNGAL was measured using a commercial enzyme-linked immunosorbent assay kit (R&D Systems). Adverse renal outcome was defined as chronic kidney disease (CKD) stage 3 or above at the last follow-up. Pearson correlation coefficient and Cox regression were used for analyses. Results: The mean age of all patients (male:female, 48:43) was 35 years (range, 18 to 77). pNGAL ranged between 21.68 and 446.40 ng/mL (median, 123.97) and showed a correlation with age (r = 0.332, p = 0.001), creatinine (r = 0.336, p = 0.001), estimated glomerular filtration rate (r = –0.397, p < 0.001), uric acid (r = 0.289, p = 0.006), and the protein-to-creatinine ratio (r = 0.288, p = 0.006). During a mean follow-up period of 37.6 months, 11 patients (12.1%) had CKD stage 3 or above. In a multivariate Cox regression model, hypertension (hazard ratio [HR], 8.779; 95% confidence interval [CI], 1.526 to 50.496; p = 0.015), proteinuria > 1 g/day (HR, 5.184; 95% CI, 1.124 to 23.921; p = 0.035), and pNGAL (HR, 1.012; 95% CI, 1.003 to 1.022; p = 0.013) were independent predictors associated with adverse renal outcome. Conclusions: pNGAL showed strong correlations with other clinical prognostic factors and was also an independent predictor of adverse renal outcome. We suggest pNGAL as a potential predictor for prognosis in IgAN, while further studies are needed to confirm the clinical value.
Abstract
Background/Aims: Neutrophil gelatinase-associated lipocalin (NGAL) is a wellknown biomarker of acute kidney injury. We evaluated the value of plasma NGAL (pNGAL) as an independent predictor of prognosis in immunoglobulin A nephropathy (IgAN). Methods: In total, 91 patients with biopsy-proven IgAN at a single center were evaluated. pNGAL was measured using a commercial enzyme-linked immunosorbent assay kit (R&D Systems). Adverse renal outcome was defined as chronic kidney disease (CKD) stage 3 or above at the last follow-up. Pearson correlation coefficient and Cox regression were used for analyses. Results: The mean age of all patients (male:female, 48:43) was 35 years (range, 18 to 77). pNGAL ranged between 21.68 and 446.40 ng/mL (median, 123.97) and showed a correlation with age (r = 0.332, p = 0.001), creatinine (r = 0.336, p = 0.001), estimated glomerular filtration rate (r = –0.397, p < 0.001), uric acid (r = 0.289, p = 0.006), and the protein-to-creatinine ratio (r = 0.288, p = 0.006). During a mean follow-up period of 37.6 months, 11 patients (12.1%) had CKD stage 3 or above. In a multivariate Cox regression model, hypertension (hazard ratio [HR], 8.779; 95% confidence interval [CI], 1.526 to 50.496; p = 0.015), proteinuria > 1 g/day (HR, 5.184; 95% CI, 1.124 to 23.921; p = 0.035), and pNGAL (HR, 1.012; 95% CI, 1.003 to 1.022; p = 0.013) were independent predictors associated with adverse renal outcome. Conclusions: pNGAL showed strong correlations with other clinical prognostic factors and was also an independent predictor of adverse renal outcome. We suggest pNGAL as a potential predictor for prognosis in IgAN, while further studies are needed to confirm the clinical value.
참고문헌 (25)
- Levy M, "Worldwide perspective of IgA nephropathy", Am J Kidney Dis, 12, pp.340~347 (1988)
- Berthoux FC, "Natural history of primary IgA nephropathy", Semin Nephrol, 28, pp.4~9 (2008)
- Xie J, "Predicting progression of IgA nephropathy: new clinical progression risk score", PLoS One, 7, pp.e38904~ (2012)
- Radford MG Jr, "Predicting renal outcome in IgA nephropathy", J Am Soc Nephrol, 8, pp.199~207 (1997)
- Bartosik LP, "Predicting progression in IgA nephropathy", Am J Kidney Dis, 38, pp.728~735 (2001)
- Devarajan P., "Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease", Scand J Clin Lab Invest Suppl, 241, pp.89~94 (2008)
- Mori K, "Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage", Kidney Int, 71, pp.967~970 (2007)
- Mori K, "Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury", J Clin Invest, 115, pp.610~621 (2005)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage", Am J Kidney Dis, 52, pp.595~605 (2008)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease", Kidney Blood Press Res, 31, pp.255~258 (2008)
- Bhavsar NA, "Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study", Am J Kidney Dis, 60, pp.233~240 (2012)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease", Clin J Am Soc Nephrol, 4, pp.337~344 (2009)
- Phillips AO., "The role of renal proximal tubular cells in diabetic nephropathy", Curr Diab Rep, 3, pp.491~496 (2003)
- Nickolas TL, "NGAL (Lcn2)monomer is associated with tubulointerstitial damage in chronic kidney disease", Kidney Int, 82, pp.718~722 (2012)
- Nielsen SE, "The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP", Scand J Clin Lab Invest, 72, pp.137~142 (2012)
- Kiryluk K, "Genetic studies of IgA nephropathy: past, present, and future", Pediatr Nephrol, 25, pp.2257~2268 (2010)
- Okazaki K, "Influence of the period between onset of IgA nephropathy and medical intervention on renal prognosis", Health, 3, pp.518~523 (2011)
- Li PK, "Prognostic indicators of IgA nephropathy in the Chinese: clinical and pathological perspectives", Nephrol Dial Transplant, 17, pp.64~69 (2002)
- D’Amico G., "Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome", Semin Nephrol, 24, pp.179~196 (2004)
- Ding H, "Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy", Clin Immunol, 123, pp.227~234 (2007)
- Peters HP, "High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy", Nephrol Dial Transplant, 26, pp.3581~3588 (2011)
- D’Amico G, "Prognostic indicators in idiopathic IgA mesangial nephropathy", Q J Med, 59, pp.363~378 (1986)
- Bogenschutz O, "IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients", Am J Nephrol, 10, pp.137~147 (1990)
- Katafuchi R, "An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis", Clin Nephrol, 41, pp.191~198 (1994)
- Goto M, "A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study", Nephrol Dial Transplant, 24, pp.3068~3074 (2009)